Heparin protects basic and acidic FGF from inactivation
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
The ability of heparin or that of hexuronyl hexosaminoglygan sulfate (HHS‐4) to protect basic or acidic fibroblast growth factor (FGF) from acid or heat inactivation has been analyzed. Both freshly prepared basic and acidic FGF stimulate the growth of baby hamster kidney (BHK‐21) cells exposed to medium supplemented with transferrin and insulin. Freshly prepared basic FGF was 10 fold more potent than acidic FGF. The addition of heparin to the medium decreased the potency of basic FGF while it potentiated that of acidic FGF. Upon storage of FGF at −80°C, a decline in potency of both basic and acidic FGF was observed. Heparin, when added to the medium, potentiated their activities, which became similar to that of freshly prepared basic FGF. In order to test whether heparin could protect basic or acidic FGF from inactivation, both mitogens were exposed to acid conditions (1% trifluoroacetic acid, pH 1.08, 2 h) or heat (65°C, 5 min) which inactivate basic or acidic FGF. When exposed to such treatment in the presence of heparin or HHS‐4, basic and acidic FGF retained their potency. The effect of heparin and HHS‐4 on the bioactivity of basic and acidic FGF is truly of a protective nature, since they had no effect when added after inactivation of the mitogens. Potentiation of the bioactivity of the protected mitogens or of the inactivated one could only be observed when cells were exposed to high heparin or HHS‐4 concentrations. This indicates that heparin and HHS‐4, in addition to protecting FGF from inactivation, also acts at another locus, as yet unidentified.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Binding of FGF-2 to heparan sulfate also imparts stability to the growth factor.”
From Interactions between extracellular matrix and growth factors in wound healing (2009) · cites this paper as [40]
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 317,331
Markwell, M. A. K., Haas, S. M., Bieber, L. L., & Tolbert, N. E. (1978) · Analytical Biochemistry · doi:10.1016/0003-2697(78)90586-9 · Cited by 6,458
Epidermal Growth Factor and a New Derivative
Savage, C. R., & Cohen, S. (1972) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)44568-7 · Cited by 1,208
Heparin Affinity: Purification of a Tumor-Derived Capillary Endothelial Cell Growth Factor
Shing, Y., Folkman, J., Sullivan, R., Butterfield, C., Murray, J., & Klagsbrun, M. (1984) · Science · doi:10.1126/science.6199844 · Cited by 933
Human Endothelial Cells: Use of Heparin in Cloning and Long-Term Serial Cultivation
Thornton, S. C., Mueller, S. N., & Levine, E. M. (1983) · Science · doi:10.1126/science.6635659 · Cited by 793
Esch, F., Baird, A., Ling, N., Ueno, N., Hill, F., Denoroy, L., Klepper, R., Gospodarowicz, D., Böhlen, P., & Guillemin, R. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.19.6507 · Cited by 693
Self-citationCultured endothelial cells produce heparinlike inhibitor of smooth muscle cell growth
Castellot, J., Addonizio, M., Rosenberg, R., & Karnovsky, M. (1981) · The Journal of Cell Biology · doi:10.1083/jcb.90.2.372 · Cited by 679
Gospodarowicz, D., Cheng, J., Lui, G. M., Baird, A., & Böhlent, P. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.22.6963 · Cited by 613
Self-citationPurification of a fibroblast growth factor from bovine pituitary.
Gospodarowicz, D. (1975) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)41631-1 · Cited by 591
Self-citationPurification of the fibroblast growth factor activity from bovine brain.
Gospodarowicz, D., Bialecki, H., & Greenburg, G. (1978) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)34863-9 · Cited by 492
Self-citation
Research works printed but not linked: 1
- Gospodarowicz D., 1986, Methods in Enzymology
Cited by
Items 601–700 of 902
van Bilsen, P. H. J., Krenning, G., Billy, D., Duval, J.-L., Huurdeman-Vincent, J., & van Luyn, M. J. A. (2008) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2008.07.013 · Cited by 19
Choi, Y. H., Ahn, H.-J., Park, M. R., Han, M.-J., Lee, J. H., & Kwon, S. K. (2018) · Acta Biomaterialia · doi:10.1016/j.actbio.2018.12.047 · Cited by 19
Kishimoto, S., Ishihara, M., Nakamura, S., Fujita, M., Takikawa, M., Sumi, Y., Kiyosawa, T., Sato, T., & Kanatani, Y. (2012) · Acta Biomaterialia · doi:10.1016/j.actbio.2012.08.003 · Cited by 19
Quantitation of basic fibroblast growth factor by immunoassay using BIAcore™ 2000
Zhu, G., Yang, B., & Jennings, R. N. (2000) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/s0731-7085(00)00417-9 · Cited by 19
Rusnati, M., Bugatti, A., Mitola, S. M. F., Leali, D., Bergese, P., Depero, L. E., & Presta, M. (2009) · Sensors · doi:10.3390/s90806471 · Cited by 19
Brown, C. A., & Halper, J. T. (1990) · Experimental Cell Research · doi:10.1016/0014-4827(90)90191-c · Cited by 19
Riss, T., & Sirbasku, D. A. (1989) · Journal of Cellular Physiology · doi:10.1002/jcp.1041380224 · Cited by 19
Microglial Activation Modulates Neuroendocrine Secretion During Experimental Sepsis
da Costa, L. H. A., Santos-Júnior, N. N., Catalão, C. H. R., & Rocha, M. J. A. (2021) · Molecular Neurobiology · doi:10.1007/s12035-020-02241-5 · Cited by 18
Patrie, K. M., Botelho, M. J., Franklin, K., & Chiu, I. (1999) · Biochemistry · doi:10.1021/bi9903345 · Cited by 18
4 Cytokines acting on committed haematopoietic progenitors
Han, Z., & Caen, J. (1994) · Baillière s Clinical Haematology · doi:10.1016/s0950-3536(05)80007-1 · Cited by 18
Purification of lipases, phospholipases and kinases by heparin-Sepharose chromatography
Farooqui, A. A., Yang, H., & Horrocks, L. A. (1994) · Journal of Chromatography A · doi:10.1016/0021-9673(94)85033-x · Cited by 18
Mohiuddin, L., Fernyhough, P., & Tomlinson, D. R. (1996) · Neuroscience Letters · doi:10.1016/0304-3940(96)12958-x · Cited by 18
Werner, S., HOFSCHNEIDER, P. H., Stürzl, M., Dick, I., & Roth, W. K. (1989) · Journal of Cellular Physiology · doi:10.1002/jcp.1041410307 · Cited by 18
A Role for Neurotrophins in the Survival of Murine Embryonic Thalamic Neurons
Lotto, R. B., Clausen, J. A., & Price, D. J. (1997) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1997.tb00761.x · Cited by 18
“When heparin was added with the object of prolonging the otherwise short half-lives of the FGFs (experiment 3b, Table 1; Gospodarowicz and Cheng, 1986; Damon et ~ l . , 1988, 1989), FGF-1 did increase viability over controls after 72 h in culture (P < 0.”
BackgroundFailure of basic fibroblast growth factor to prevent postischemic neuronal damage in the rat
Hara, H., Onodera, H., Kawagoe, J., & Kogure, K. (1991) · European Journal of Pharmacology · doi:10.1016/0014-2999(91)90169-q · Cited by 18
Expression of fibroblast growth factor by F9 teratocarcinoma cells as a function of differentiation.
Braunhut, S. J., Gudas, L. J., Kurokawa, T., Sasse, J., & D'Amore, P. A. (1989) · The Journal of Cell Biology · doi:10.1083/jcb.108.6.2467 · Cited by 18
Davies, M. J., Mitchell, C. A., Maley, M. A. L., Grounds, M. D., Harvey, A. R., Plant, G. W., Wood, D., Hong, Y., & Chirilă, T. V. (1997) · Journal of Biomaterials Applications · doi:10.1177/088532829701200103 · Cited by 17
Kunou, M., & Hatanaka, K. (1995) · Carbohydrate Polymers · doi:10.1016/0144-8617(95)00101-8 · Cited by 17
Mesoglycan and Sulodexide Act as Stabilizers and Protectors of Fibroblast Growth Factors (FGFs)
Tardieu, M., Bourin, M., Desgranges, P., Barbier, P., Barritault, D., & Caruelle, J. P. (1994) · Growth Factors · doi:10.3109/08977199409011002 · Cited by 17
Vannucchi, S., Pasquali, F., Fiorelli, G., Biabchini, P., & Ruggiero, M. (1990) · FEBS Letters · doi:10.1016/0014-5793(90)80723-v · Cited by 17
Emoto, N., Onose, H., Sugihara, H., Minami, S., Shimizu, K., & Wakabayashi, I. (1998) · Thyroid · doi:10.1089/thy.1998.8.491 · Cited by 17
“Heparan sulfates on the surface of cells are necessary for bioactivity of FGF-2 in many (20-22) but not all cells including thyroid (23,24), and the proteo-glycans in the ECM could protect FGF-2 from degradation (25).”
Ashton, A. W., Dawes, J., & Chesterman, C. N. (1995) · Growth Factors · doi:10.3109/08977199509028957 · Cited by 17
Endothelia Cell Growth Factor (ECGF) Application to Irradiated Soft Tissue
Hom, D. B., Assefa, G., & Song, C. W. (1993) · The Laryngoscope · doi:10.1002/lary.5541030208 · Cited by 17
Kasayama, S., Sumitani, S., Tanaka, A., Yamanishi, H., Nakamura, N., Matsumoto, K., & Sato, B. (1991) · Journal of Cellular Physiology · doi:10.1002/jcp.1041480211 · Cited by 17
Heparin and Growth Control of Vascular Cellsa
Thompson, R. W., Orlidge, A., & D'Amore, P. A. (1989) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1989.tb22508.x · Cited by 17
Proteoglycan-Growth Factor Interactions.
Yamaguchi, Y. (1993) · Trends in Glycoscience and Glycotechnology · doi:10.4052/tigg.5.428 · Cited by 17
Enhanced random skin flap survival by sustained delivery of fibroblast growth factor 2 in rats
Park, H. J., Lee, S., Kang, K. H., Heo, C. Y., Kim, J. H., Yang, H. S., & Kim, B. (2012) · ANZ Journal of Surgery · doi:10.1111/j.1445-2197.2012.06194.x · Cited by 16
Lei, J. L., Treviño, E. A., & Temenoff, J. S. (2016) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.35713 · Cited by 16
“Because heparin is known to preserve the bioactivity of FGF-2, 30,31 it is possible that the presence of a Hep coating may simply be maintaining higher levels of active growth factor in the culture media.”
Chum, Z. Z., Woodruff, M. A., Cool, S. M., & Hutmacher, D. W. (2009) · Acta Biomaterialia · doi:10.1016/j.actbio.2009.05.015 · Cited by 16
Interaction of basic fibroblast growth factor with bovine growth plate chondrocytes
Trippel, S. B., Whelan, M. C., Klagsbrun, M., & Doctrow, S. R. (1992) · Journal of Orthopaedic Research® · doi:10.1002/jor.1100100506 · Cited by 16
Sakaguchi, K., Lorenzi, M. V., Bottaro, D. P., & Miki, T. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.10.6754 · Cited by 16
“Furthermore, the HSGAG on the receptor might also protect the ligand from degradation by proteases and thereby prolong the activation of FGFR, as reported for the cell surface HSGAG (6, 10, 19, 30, 33, 38).”
BackgroundKan, M., & Shi, E. (1990) · In Vitro Cellular & Developmental Biology - Plant · doi:10.1007/bf02623692 · Cited by 16
“Although HBGF-1 has lower aiTmity than HBGF-2 for heparin, the glycosaminoglycan protects both HBGF-1 and HBGF-2 against inactivation by protease (Gospodarowicz and Cheng, 1986) and has two selective effects on HBGF-1 relative to HBGF-2: a) the optimal mitogenic effect of HBGF-1 requires heparin; and b) beparin protec…”
BackgroundGospodarowicz, D., & Cheng, J. (1987) · In Vitro Cellular & Developmental Biology - Plant · doi:10.1007/bf02628421 · Cited by 16
“potencies when FGFs were tested on a wide variety of normal diploid cell types (2) or established cell lines (10,27,28).”
BackgroundResultSelf-citationHigh yield purification of melanoma growth stimulatory activity
Thomas, H. G., & Richmond, A. J. (1988) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(88)90033-0 · Cited by 16
Murono, E. P., Washburn, A. L., Goforth, D. P., & Wu, N. (1993) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(93)90082-u · Cited by 16
Talarico, D., Ittmann, M., Bronson, R. T., & Basilico, C. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.4.1998-2010.1993 · Cited by 16
“Heparin or heparan sulfates appear to protect FGFs from degradation, and they may play a role in providing a cell surface-bound reservoir of the growth factors (12, 27, 45).”
BackgroundWille, I., Harre, J., Oehmichen, S., Lindemann, M., Menzel, H., Ehlert, N., Lenarz, T., Warnecke, A., & Behrens, P. J. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.776890 · Cited by 15
Rival, D., Bonnet, S., Sohm, B., & Perrier, É. (2009) · International Journal of Cosmetic Science · doi:10.1111/j.1468-2494.2009.00538.x · Cited by 15
Thomas, K. A., Ortega, S., Soderman, D. D., Schaeffer, M., DiSalvo, J., Giménez‐Gallego, G., Linemeyer, D. L., Kelly, L. J., & Menke, J. G. (1991) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1991.tb49013.x · Cited by 15
Sulphated polysaccharides derived from dextran: biomaterials for vascular therapy
Chaubet, F., Huynh, R., Champion, J., Jozefonvicz, J., & Letourneur, D. (1999) · Polymer International · doi:10.1002/(sici)1097-0126(199904)48:4<313::aid-pi151>3.0.co;2-h · Cited by 15
Li, K., Karaganis, A. G., & Shain, S. A. (1992) · Protein Expression and Purification · doi:10.1016/1046-5928(92)90067-7 · Cited by 15
Delehedde, M., Deudon, E., Boilly, B., & Hondermarck, H. (1997) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(19970315)64:4<605::aid-jcb9>3.0.co;2-v · Cited by 15
Detergent-solubilized proteoglycans in rat testicular sertoli cells
Mounis, A., Barbey, P., Langris, M., & Bocquet, J. (1991) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(91)90095-x · Cited by 15
Modulation of growth of human carcinoma SW‐13 cells by heparin and growth factors
Halper, J. T., & Carter, B. J. (1989) · Journal of Cellular Physiology · doi:10.1002/jcp.1041410104 · Cited by 15
Transport and gradient formation of Wnt and Fgf in the early zebrafish gastrula
Cooper, E. J., & Scholpp, S. (2023) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/bs.ctdb.2023.12.003 · Cited by 14
Zayas, J. R., & Schwarz, R. I. (1992) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/bf02631063 · Cited by 14
Chopra, P., Logun, M. T., White, E. M., Lü, W., Locklin, J., Karumbaiah, L., & Boons, G. (2019) · ACS Chemical Biology · doi:10.1021/acschembio.9b00401 · Cited by 14
Fu, L., Li, R., Whitelock, J. M., & Lord, M. S. (2022) · Regenerative Biomaterials · doi:10.1093/rb/rbac081 · Cited by 14
“growth factors such as FGF2 [60] and this was explored in the”
BackgroundCharacterization of Chitosan Films for Cell Culture Applications
Katalinich, M. (2001) · DigitalCommons (California Polytechnic State University) · Cited by 14
Distribution of fibroblast growth factors in cultured tumor cells and their transplants
Yoshitake, Y., & Nishikawa, K. (1992) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/bf02634046 · Cited by 14
“Heparin has also been shown to inhibit the cleavage of aFGF by proteases (9,25,51) and to protect FGFs from heat- or acid-inactivation ( 15 ).”
BackgroundIn vivo activities of acidic fibroblast growth factor-Pseudomonas exotoxin fusion proteins
Siegall, C. B., Gawlak, S. L., Chace, D. F., Merwin, J. R., & Pastan, I. H. (1994) · Bioconjugate Chemistry · doi:10.1021/bc00025a010 · Cited by 14
Effects of Basic Fibroblast Growth Factor on in Vivo Cerebral Tumorigenesis in Rats
Segal, D. H., Germano, I. M., & Bederson, J. B. (1997) · Neurosurgery · doi:10.1097/0006123-199705000-00028 · Cited by 14
Rifkin, D. B., Moscatelli, D., Flaumenhaft, R. C., Sato, Y., Saksela, O., & Tsuboi, R. (1991) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1991.tb43707.x · Cited by 14
Miura, T., Kawano, M., Takahashi, K., Yuasa, N., Habu, M., Kimura, F., Imamura, T., & Nakayama, F. (2022) · Advances in Radiation Oncology · doi:10.1016/j.adro.2022.100900 · Cited by 13
Heparin-binding growth factors and their receptors
Olwin, B. B. (1989) · Cytotechnology · doi:10.1007/bf00364998 · Cited by 13
The effects of growth factors on Tenon's capsule fibroblasts in serum-free culture
Ellis, D. G., Cheng, Q., & Lee, D. A. (1996) · Current Eye Research · doi:10.3109/02713689609017608 · Cited by 13
Controlled Release of Fibroblast Growth Factor: Activity in Cell Culture
Nugent, M. A., Chen, O. S., & Edelman, E. R. (1991) · MRS Proceedings · doi:10.1557/proc-252-273 · Cited by 13
de Yébenes, J. G., Sánchez‐Pernaute, R., Garrido, J. M., Rábano, A., Albísua, J., Rojo, A., Mena, M. A., Ruiz, P., Jorge, P., Corrêa, C., et al. (1998) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(98)00025-x · Cited by 13
Riss, T., Karey, K. P., Burleigh, B. D., Farker, D., & Sirbasku, D. A. (1988) · In Vitro Cellular & Developmental Biology - Plant · doi:10.1007/bf02620811 · Cited by 13
“Addition of heparin (100 ng/ml), reported to be a stabilizing agent for bFGF ( 19 ), resulted in a slight decrease in cell number.”
BackgroundFluorospectrometric Analysis of Heparin Interaction with Fibroblast Growth Factors
Li, L.-Y., & Seddon, A. P. (1994) · Growth Factors · doi:10.3109/08977199409015046 · Cited by 13
Hill, C. E., Belford, D. A., Godovac‐Zimmermann, J., & Hendry, I. A. (1991) · Developmental Brain Research · doi:10.1016/0165-3806(91)90062-n · Cited by 13
Dziarski, R. (1992) · Cellular Immunology · doi:10.1016/0008-8749(92)90316-h · Cited by 12
Nanomechanics on FGF-2 and Heparin Reveal Slip Bond Characteristics with pH Dependency
Sevim, S., Özer, S., Jones, G., Wurzel, J., Feng, L., Fakhraee, A., Shamsudhin, N., Ergeneman, O., Pellicer, E., Sort, J., et al. (2017) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.6b00723 · Cited by 12
“It is for this mechanism that the activity of FGF-2 is linked to ECM remodeling, degradation and turnover.(8) As potent mitogenic growth factor, FGF-2 is spatially and temporarily tightly regulated during embryonal development and in tissue repair(9-10), showing proliferative effects on a large number of cell types de…”
BackgroundBasic fibroblast growth factor binding and processing by human glioma cells
Murphy, P. R., & Knee, R. S. (1995) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(95)96800-w · Cited by 12
Somers, P., Narine, K., Somer, F. M. J. J. D., de Vos, F., & Nooten, G. V. (2008) · Growth Factors · doi:10.1080/08977190802303645 · Cited by 12
“The capacity of heparin to interact with bFGF and bFGF-R is determined by its negatively charged HS chains (Gospodarowicz and Cheng 1986).”
BackgroundInfluentialA bio-inspired hybrid nanosack for graft vascularization at the omentum
Hwang, P. T. J., Lim, D., Fee, T. J., Alexander, G. C., Tambralli, A., Andukuri, A., Tian, L., Cui, W., Berry, J. L., Gilbert, S. R., et al. (2016) · Acta Biomaterialia · doi:10.1016/j.actbio.2016.06.011 · Cited by 12
“Heparin also protects FGF-2 from inactivation and helps to preserve the efficacy of FGF-2 even in harsh environments [53].”
BackgroundHeparin beschleunigt die Proliferation humaner Osteoblasten in vitro
Matziolis, G., Erli, H. J., Rau, H. M., Klever, P., Bosserhoff, A., & Paar, O. (2002) · Der Orthopäde · doi:10.1007/s00132-002-0308-y · Cited by 12
Biotinylated basic fibroblast growth factor is biologically active
Pieri, I., & Barritault, D. (1991) · Analytical Biochemistry · doi:10.1016/0003-2697(91)90319-o · Cited by 12
Arakawa, T., Hoist, P., Narhi, L. O., Philo, J. S., Wen, J., Prestrelski, S. J., Zhu, X., Rees, D. C., & Fox, G. M. (1995) · Journal of Protein Chemistry · doi:10.1007/bf01886783 · Cited by 12
Binding of heparin to human microvascular endothelial cells and the effect on proliferation
Bikfalvi, A., Dupuy, É., RUAN, C., Tobelem, G., Lesèche, G., & Caen, J. (1988) · Cell Biology International Reports · doi:10.1016/0309-1651(88)90161-0 · Cited by 12
Jerg, K. R., Baumann, H., Keller, R., & Friedl, P. (1990) · International Journal of Biological Macromolecules · doi:10.1016/0141-8130(90)90067-k · Cited by 12
Serial passage of embryonic human astrocytes in serum‐free, hormone‐supplemented medium
Loo, D. T., Sakai, Y., Rawson, C., & Barnes, D. W. (1991) · Journal of Neuroscience Research · doi:10.1002/jnr.490280110 · Cited by 12
“The medium employed for serum-free culture of human astrocytes was a modification of the medium used for SFME cells; FGF was added in addition to the other components and heparin also was added to stabilize FGF in the culture medium (Gospodarowicz and Cheng, 1986).”
Sulfated and Phosphorylated Agarose as Biomaterials for a Biomimetic Paradigm for FGF-2 Release
Forget, A., & Shastri, V. P. (2024) · Biomimetics · doi:10.3390/biomimetics10010012 · Cited by 11
Exploring single-molecule interactions: heparin and FGF-1 proteins through solid-state nanopores
Thyashan, N., Ghimire, M., Lee, S., & Kim, M. J. (2024) · Nanoscale · doi:10.1039/d4nr00274a · Cited by 11
Yasunaga, M., Kobayashi, F., Sogo, Y., Murotomi, K., Hirose, M., Hara, Y., Yamazaki, M., & Ito, A. (2022) · Acta Biomaterialia · doi:10.1016/j.actbio.2022.06.013 · Cited by 11
Adhirajan, N., Rajangam, T., Naveen, N. R., Sivagnanam, U. T., & Babu, M. (2014) · Polymer Bulletin · doi:10.1007/s00289-014-1108-3 · Cited by 11
“Several of these growth factors have been shown to bind to heparin and this binding stabilizes and protects these growth factors from inactivation and degradation [11].”
BackgroundKishimoto, S., Ishihara, M., Takikawa, M., Mori, Y., Hattori, H., Fujita, M., & Nakamura, S. (2012) · Pharmaceutics · doi:10.3390/pharmaceutics4010042 · Cited by 11
“Some heparinoids can prolong the biological half-life of FGF-2 as well as protect FGF-2 from heat, acid, and proteolytic inactivation [30].”
BackgroundEstablishing Early Functional Perfusion and Structure in Tissue Engineered Cardiac Constructs
Wang, B., Patnaik, S. S., Brazile, B. L., Butler, J. R., Claude, A. K., Zhang, G., Guan, J., Hong, Y., & Liao, J. (2015) · Critical Reviews in Biomedical Engineering · doi:10.1615/critrevbiomedeng.2016016066 · Cited by 11
Capturing Identity and Fate Ex Vivo
Garg, V., Morgani, S. M., & Hadjantonakis, A. (2016) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/bs.ctdb.2016.04.007 · Cited by 11
“…for TS cells routinely include FGF4, heparin (which prevents pro- teolytic cleavage of FGF and aids in signal transduction via FGF dimeriza- tion; Gospodarowicz & Cheng, 1986; Ornitz et al., 1992; Saksela, Moscatelli, Sommer, & Rifkin, 1988), and mouse embryonic fibroblast (MEF) feeders that…”
BackgroundHeparin is biocompatible and can induce differentiation of human dental pulp cells
Rodrigues, E. M., Cornélio, A. L. G., Godoi, P. H., da Costa, P. I., Rossa, C., Faria, G., Guerreiro‐Tanomaru, J. M., & Tanomaru‐Filho, M. (2018) · International Endodontic Journal · doi:10.1111/iej.13061 · Cited by 11
“This interaction occurs in part by shape recognition, but primarily as electrostatic attractions between N- and O-sulfated residues of heparin and the lysine and arginine residues of the BMP-2 (Gospodarowicz & Cheng 1986, Wissink et al. 2000).”
BackgroundNucleosomes Bind Fibroblast Growth Factor-2 for Increased Angiogenesis In vitro and In vivo
Tanner, J. E., Forté, A. J., & Panchal, C. J. (2004) · Molecular Cancer Research · doi:10.1158/1541-7786.281.2.5 · Cited by 11
Gruber, B. L. (1994) · Clinics in Dermatology · doi:10.1016/0738-081x(94)90292-5 · Cited by 11
Ikemoto, M., Hasegawa, K., Kihara, Y., Iwakura, A., Komeda, M., Yamazato, A., & Fujita, M. (1999) · Clinica Chimica Acta · doi:10.1016/s0009-8981(99)00045-5 · Cited by 11
Structure and function of the heparin-binding (fibroblast) growth factor family
Hearn, M. T. W. (1991) · Baillière s Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(10)80004-7 · Cited by 11
Heparin potentiates the action of plasma membrane‐associated growth stimulatory activity
Nagasaki, T., & Lieberman, M. A. (1987) · Journal of Cellular Physiology · doi:10.1002/jcp.1041330222 · Cited by 11
Engineering a heparin-mimetic biomaterial to promote tissue vascularization
Li, L., Yang, J., Perry, L., Bays, J., Bhatia, S. N., Eyckmans, J., & Chen, C. S. (2025) · Communications Biology · doi:10.1038/s42003-025-08946-4 · Cited by 10
Mechanisms of Cell Growth Regulation by Heparin and Heparan Sulfate
Nugent, M. A., Forsten‐Williams, K., Karnovsky, M. J., & Edelman, E. R. (2005) · Elsevier eBooks · doi:10.1016/b978-008044859-6/50020-4 · Cited by 10
Gelatin device for the delivery of growth factors involved in endochondral ossification
Ahrens, L., Vonwil, D., Christensen, J., & Shastri, V. P. (2017) · PLoS ONE · doi:10.1371/journal.pone.0175095 · Cited by 10
Jiang, S., Wu, J., Hang, Y., Liu, Q., Li, D., Chen, H., & Brash, J. L. (2019) · Journal of Materials Chemistry B · doi:10.1039/c9tb00714h · Cited by 10
Sauer, D. G., Mosor, M., Jungbauer, A., & Dürauer, A. (2020) · Separation and Purification Technology · doi:10.1016/j.seppur.2020.117564 · Cited by 10
Heparin-Functionalized Materials in Tissue Engineering Applications
McGann, C. L., & Kiick, K. L. (2011) · Springer eBooks · doi:10.1007/978-1-4614-1080-5_9 · Cited by 10
Schöfer, C., Frei, K., Weipoltshammer, K., & Wachtler, F. J. (2001) · Anatomy and Embryology · doi:10.1007/s004290000148 · Cited by 10
“50 µl of a suspension of heparin ( Gospodarowicz and Cheng, 1986 ) immobilized on acrylic beads in 0.15 M NaCl (catalog no. H-5263, Sigma) were centrifuged and the pellet was resuspended in 80 µl of growth factor solution.”
MethodInfluentialTechniques to Enhance Extramyocardial Collateral Blood Flow After a Cardiomyoplasty
Mannion, J. D., Magno, M. G., Buckman, P. D., Bailey, W., Blood, V., Heiman-Patterson, T. D., Edie, R. N., & Rosato, F. E. (1993) · Annals of Surgery · doi:10.1097/00000658-199310000-00014 · Cited by 10
Willson, M., Périé, J. J., Malecaze, F., Opperdoes, F. R., & Callens, M. C. (1992) · European Journal of Medicinal Chemistry · doi:10.1016/0223-5234(92)90114-g · Cited by 10
Tazawa, S., Hayakawa, Y., Ishikawa, T.-I., Niiya, K., & Sakuragawa, N. (1993) · Thrombosis Research · doi:10.1016/0049-3848(93)90243-h · Cited by 10
Rieck, P. W., Denis, J., Peters, D., Hartmann, C. J., Pouliquen, Y. J. M., & Courtois, Y. (1997) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/bf01880673 · Cited by 10
Heparin induces fibroblast proliferation, cell‐matrix interaction and epidermal growth inhibition
Imaizumi, T., Jean‐Louis, F., Dubertret, M., & Dubertret, L. (1996) · Experimental Dermatology · doi:10.1111/j.1600-0625.1996.tb00100.x · Cited by 10
Protein Adsorption and Cellular/Tissue Interactions
Magnani, A., Peluso, G., Margarucci, S., & Chittur, K. K. (2005) · Kluwer Academic Publishers eBooks · doi:10.1007/0-306-47583-9_24 · Cited by 10
“Heparin sulfate, a structural component of the ECM, may function to stabilize FGFs, since it protects both bFGF and aFGF from acid or heat inactivation and potentiates their mitogenic activity ( Gospodarowicz and Cheng, 1986 ).”
BackgroundWong, P., & Burgess, W. H. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.29.18617 · Cited by 10
Rybak, S. M., Lobb, R. R., & Fett, J. W. (1988) · Journal of Cellular Physiology · doi:10.1002/jcp.1041360214 · Cited by 10
Metadata
- Authors
- Gospodarowicz, D., & Cheng, J.
- Affiliations
- University of California, San Francisco (US)
- Corresponding author
- Gospodarowicz, D.
- Venue
- Journal of Cellular Physiology
- Publisher
- Wiley
- Published
- 1986-09
- Volume
- 128
- Issue
- 3
- Pages
- 475-484
- ISSN
- 0021-9541 (ISSN-L)
- 1097-4652
- OpenAlex
- W1972855766
- Cited by
- 853
- References
- 30
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 8 · 2023: 6 · 2022: 11 · 2021: 13 · 2020: 10 · 2019: 12 · 2018: 9 · 2017: 8 · 2016: 18 · 2015: 10 · 2014: 9 · 2013: 11 · 2012: 22
- FWCI
- 14.52
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Cellular Physiology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Heart, Lung, and Blood Institute (HL 20197)
- National Eye Institute (EY02186)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fibroblast Growth Factor Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Proteoglycans and glycosaminoglycans research
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- heparin, basic fibroblast growth factor, acidic fibroblast growth factor, acid inactivation, thermal inactivation
- MeSH terms
- Animals, Cell Division, Cell Line, Fibroblast Growth Factors, Fibroblasts, Glycosaminoglycans, Cricetinae, Hot Temperature, Heparin, Hydrogen-Ion Concentration, Insulin, Kidney, Mesocricetus, Transferrin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.